Genetic testing for prevention and treatment of cancer
Tidsskr Nor Laegeforen, 144 (13)
DOI 10.4045/tidsskr.24.0434, PubMed 39498653
Gene-based burden tests of rare germline variants identify six cancer susceptibility genes
Nat Genet (in press)
DOI 10.1038/s41588-024-01966-6, PubMed 39472694
The SRC-family serves as a therapeutic target in triple negative breast cancer with acquired resistance to chemotherapy
Br J Cancer (in press)
DOI 10.1038/s41416-024-02875-5, PubMed 39390250